Terms: = Gastric cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
695 results:
1. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract] [Full Text] [Related]
2. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
3. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.
Lim LM; Lee YC; Lin TW; Hong ZX; Hsu WC; Ke HL; Hwang DY; Chung WY; Li WM; Lin HH; Kuo HT; Huang AM
Kaohsiung J Med Sci; 2024 May; 40(5):445-455. PubMed ID: 38593276
[TBL] [Abstract] [Full Text] [Related]
4. Nanoparticles for Augmenting Therapeutic Potential and Alleviating the Effect of Di(2-ethylhexyl) Phthalate on gastric cancer.
Huang HL; Chen KW; Liao HW; Wang LY; Peng SL; Lai CH; Lin YH
ACS Appl Mater Interfaces; 2024 Apr; 16(15):18285-18299. PubMed ID: 38574184
[TBL] [Abstract] [Full Text] [Related]
5. Fat mass and obesity-associated protein (FTO) mediated m
Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P
Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586
[TBL] [Abstract] [Full Text] [Related]
6. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mtor signaling pathway.
Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
[TBL] [Abstract] [Full Text] [Related]
7. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mtor signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
8. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mtor-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
9. Pectolinarigenin regulates the tumor-associated proteins in AGS-xenograft BALB/c nude mice.
Lee HJ; Kwon YS; Lee JH; Moon YG; Choi J; Hyun M; Tak TK; Kim JH; Heo JD
Mol Biol Rep; 2024 Feb; 51(1):305. PubMed ID: 38361124
[TBL] [Abstract] [Full Text] [Related]
10. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract] [Full Text] [Related]
11. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
12. Targeting PI3K/AKT/mtor and MAPK Signaling Pathways in gastric cancer.
Morgos DT; Stefani C; Miricescu D; Greabu M; Stanciu S; Nica S; Stanescu-Spinu II; Balan DG; Balcangiu-Stroescu AE; Coculescu EC; Georgescu DE; Nica RI
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339127
[TBL] [Abstract] [Full Text] [Related]
13. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mtor Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [
